| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Director | Common Stock | 22,500 | $1,709,100 | $75.96 | 02 Jan 2026 | Direct |
| NEXGEL, INC. | Director | Common Stock | 106,664 | $293,326 | $2.75 | 20 Nov 2024 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 3,475 | $238,040 | $27.05 | 02 Jan 2026 | Direct |
| NexImmune, Inc. | Executive VP of Research & Dev | Stock Option (Right to Buy) | 80,100 | 05 Apr 2022 | Direct | ||
| NEXGEL, INC. | Director | Stock Option (Right to Buy) | 30,000 | 25 Jun 2025 | Direct | ||
| SOLIGENIX, INC. | Director | Stock Option (Right to Buy) | 17,647 | 20 Jun 2025 | Direct | ||
| NEXGEL, INC. | Director | Warrant to Purchase Common Stock | 1,818 | 20 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | 02 Jan 2026 | 2 | $0 | 4 | Director | 06 Jan 2026, 17:20 |
| NXGL | NEXGEL, INC. | 25 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 20:00 |
| SNGX | SOLIGENIX, INC. | 20 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 16:27 |
| PTCT | PTC THERAPEUTICS, INC. | 03 Jan 2025 | 2 | $0 | 4 | Director | 07 Jan 2025, 17:20 |
| SNGX | SOLIGENIX, INC. | 12 Dec 2024 | 1 | $0 | 4 | Director | 13 Dec 2024, 16:22 |
| PTCT | PTC THERAPEUTICS, INC. | 02 Dec 2024 | 9 | -$253,577 | 4 | Director | 04 Dec 2024, 17:20 |
| NXGL | NEXGEL, INC. | 20 Nov 2024 | 2 | +$9,999 | 4 | Director | 22 Nov 2024, 16:54 |
| NXGL | NEXGEL, INC. | 13 Sep 2024 | 1 | $0 | 4 | Director | 17 Sep 2024, 17:27 |
| NXGL | NEXGEL, INC. | 23 Aug 2024 | 2 | +$25,000 | 4 | Director | 27 Aug 2024, 21:13 |
| PTCT | PTC THERAPEUTICS, INC. | 22 May 2024 | 3 | -$236,400 | 4 | Director | 24 May 2024, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 15 Feb 2024 | 2 | $0 | 4 | Director | 16 Feb 2024, 16:10 |
| SNGX | SOLIGENIX, INC. | 15 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 16:10 |
| NXGL | NEXGEL, INC. | 17 Aug 2023 | 1 | $0 | 4 | Director | 21 Aug 2023, 16:34 |
| NXGL | NEXGEL, INC. | 26 May 2023 | 1 | +$11,688 | 4 | Director | 30 May 2023, 16:05 |
| PTCT | PTC THERAPEUTICS, INC. | 05 Jan 2023 | 2 | $0 | 4 | Director | 09 Jan 2023, 15:16 |
| SNGX | SOLIGENIX, INC. | 17 Nov 2022 | 1 | $0 | 4 | Director | 21 Nov 2022, 15:33 |
| /report/000120919122023746-zeldis-jerome-b-2022-04-05 | NexImmune, Inc. | 05 Apr 2022 | 1 | $0 | 4 | Executive VP of Research & Dev | 07 Apr 2022, 19:12 |
| NXGL | NEXGEL, INC. | 25 Mar 2022 | 1 | +$10,010 | 4 | Director | 28 Mar 2022, 16:07 |
| PTCT | PTC THERAPEUTICS, INC. | 07 Jan 2022 | 2 | $0 | 4 | Director | 11 Jan 2022, 15:10 |
| NXGL | NEXGEL, INC. | 27 Dec 2021 | 2 | +$50,000 | 4 | Director | 03 Jan 2022, 15:46 |
| SNGX | SOLIGENIX, INC. | 23 Sep 2021 | 1 | $0 | 4 | Director | 24 Sep 2021, 16:12 |
| SNGX | SOLIGENIX, INC. | 14 May 2021 | 2 | -$36.6 | 4 | Director | 18 May 2021, 17:00 |